End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
124 MXN | -2.36% |
|
-.--% | -2.36% |
Evolution of the average Target Price on Marinus Pharmaceuticals, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
![Consensus](/images/consensus_flch.gif)
Consensus detail
Consensus revision (last 18 months)
Analysts covering Marinus Pharmaceuticals, Inc.
HC Wainwright | |
Truist Securities | |
Baird | |
RBC Capital Markets | |
Ladenburg Thalmann | |
Oppenheimer | |
JMP Securities | |
SVB Securities LLC | |
Cantor Fitzgerald | |
SVB Leerink |
EPS Revisions
- Stock Market
- Equities
- MRNS Stock
- MRNS * Stock
- Consensus Marinus Pharmaceuticals, Inc.